This technology is the first in-market solution to enable visualization of hemoglobin oxygen saturation (StO2) levels in tissue during laparoscopic and endoluminal procedures

Lexington, Mass., August 24, 2021 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, today announced that it has been awarded a 10-year sole source contract for its innovative digital radiography (DR) systems from the U.S. Navy and Defense Logistics Agency (DLA).

Fujifilm’s ASPIRE Cristalle now offers ScreenPoint Medical’s Transpara® powered by Fusion AI™ for 2D and 3D mammography 

Company to showcase new enterprise-wide, zero-footprint platform, Synapse 7x, Advancements in AI, and Key Clinical Partnership

AHRA conference attendees will see firsthand how Fujifilm’s wide range of diagnostic solutions are designed with the aim to help enable fast confident diagnosis and enhanced patient experiences

Lexington, Mass., July 14, 2021 - Fujifilm today announced the launch of the Fujifilm Virtual Hospital. The virtual hospital presents visitors with an interactive environment where they can view and learn about Fujifilm’s robust portfolio of healthcare solutions, and discover how the company’s diagnostic, treatment and research technologies advance the entire continuum of patient care. 

Lexington, MASS.–  July 26, 2021 –  FUJIFILM Medical Systems U.S.A, Inc., a leading provider of Enterprise Imaging and Informatics solutions, today announced that its next-generation Synapse® Enterprise Information System (EIS) has been selected by US Radiology Specialists – one of the country’s largest radiology groups – to drive efficient and high quality patient care

This FDA-designated Breakthrough Device is now cleared and is scheduled to commercialize late-summer

Company has scaled its OR Integration capabilities to advance care delivery in Endoscopy Suites